Biological Activity Of miRNA-27a Using Peptide-based Drug Delivery Systems

Anna-Laurence Schachner-Nedherer1, Oliver Werzer1, Karin Kornmueller2

  • 1Department of Pharmaceutical Technology and Biopharmacy, Institute of Pharmaceutical Sciences, University of Graz, Graz 8010, Austria.

Abstract

Insights

N-TER peptide drug delivery systems effectively deliver miRNA-27a to inhibit fat accumulation in adipocytes. This approach shows promise for treating obesity and related disorders through miRNA mimic replacement therapy.

Area of Science:

  • Biochemistry and Molecular Biology
  • Biotechnology
  • Cell Biology

Background:

  • MicroRNAs (miRNAs) regulate gene expression and are implicated in diseases like obesity.
  • miRNA-27a shows potential for inhibiting adipogenic genes, but naked nucleic acids have delivery challenges.
  • Developing effective drug delivery systems (DDS) for miRNAs is crucial for therapeutic applications.

Purpose of the Study:

  • To develop and evaluate a novel drug delivery system (DDS) for miRNA-27a.
  • To investigate the anti-adipogenic effects of miRNA-27a delivered via the N-TER peptide DDS.
  • To assess the potential of this approach for obesity treatment.

Main Methods:

  • Utilized a combination of atomic force microscopy (AFM), brightfield (BF), and fluorescence microscopy to study N-TER peptide-nucleic acid complex interactions.
  • Employed confocal laser scanning microscopy (cLSM) for time-dependent cellular uptake studies.
  • Assessed anti-adipogenic effects using Oil-Red-O (ORO) staining and absorbance measurements in 3T3-L1 adipocytes.

Main Results:

  • Amphipathic N-TER peptides formed stable, non-covalent complexes with miRNAs via electrostatic interactions.
  • N-TER peptide-nucleic acid complexes demonstrated effective cellular adhesion, uptake, and intracellular miRNA release.
  • miRNA-27a delivery via N-TER peptides significantly reduced lipid droplet accumulation in mature adipocytes, indicating an anti-adipogenic effect.

Conclusions:

  • The N-TER peptide-based DDS successfully delivered miRNA-27a to induce anti-adipogenic effects in adipocytes.
  • This DDS approach offers a promising strategy for miRNA mimic replacement therapy.
  • The findings suggest potential therapeutic applications for preventing and treating obesity and associated disorders.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K